SEARCH BY
| Category | Company |
|---|---|
| Founded | 1994 |
| Sector | Life Science |
| Employees | 1,147 |
| Revenue | 2.2B USD (2024) |
Exelixis is a biopharmaceutical company focused on developing and commercializing small molecule therapies with the potential to improve the treatment of cancer. Exelixis was founded in 1994 and is based in Alameda, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 3 |
| Sector: Life Science M&A | 1 of 3 |
| Type: Add-on Acquisition M&A Deals | 1 of 2 |
| State: Oregon M&A | 1 of 1 |
| Country: United States M&A | 1 of 2 |
| Year: 2000 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2005-01-14 |
X-Ceptor Therapeutics
San Diego, California, United States X-Ceptor Therapeutics, Inc. discovers and develops novel small molecule therapeutics that modulate nuclear receptors. |
Buy | - |